Reflectance Medical Inc. is an early stage company developing new technology to revolutionize the care 
of critically ill patients by reducing medical costs and deaths associated with conditions which result in 
poor tissue perfusion and acidosis. The company's noninvasive CareGuide patient monitor continuously 
and quantitatively displays levels of microvascular oxygen, pH and hematocrit to provide treatment goals 
to assure rapid and successful reversal of microvascular abnormalities associated with internal
bleeding, trauma, cardiac failure and sepsis.